Molecular Docking of New Active Compounds Towards the Acetylcholinesterase Enzyme
Lemaoui Tarek1, Hammoudi Nour El Houda1, Benguerba Yacine1 & Attoui Ayoub1 Show affiliations
- Université Ferhat ABBAS Sétif-1, Algeria
Current Research in Bioinformatics, Volume 8, Issue 1, pp. 18–20 · doi.org/10.3844/ajbsp.2019.18.20
Abstract
Molecular docking is a key instrument in structural molecular biology and computer-assisted drug design. The objective of ligand-protein docking is to expect the main binding mode(s) of a ligand with a protein of known three-dimensional structure. Effective docking methods search high-dimensional spaces effectively and finding a scoring function that correctly ranks candidate dockings (Morris et al., 2008). In this study molecular docking study was performed for 54 Acetylcholinesterase Inhibitors compounds.
Licence and reuse
Open access. This article is licensed under a Creative Commons Attribution 3.0 Licence (CC BY 3.0), as printed on the article, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original authors and the source. No permission is needed.
How to reuse this articleResponses (0)
About this article
Tarek, L., El Houda, H. N., Yacine, B. & Ayoub, A. (2019). Molecular Docking of New Active Compounds Towards the Acetylcholinesterase Enzyme. Current Research in Bioinformatics, 8(1), 18–20. https://doi.org/10.3844/ajbsp.2019.18.20
- Licence
- CC BY 3.0
- Issue
- Volume 8, Issue 1
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record